Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
VC
Vivo Capital, LLC
|
550.0K | 1.95% | −1.2M (−69.3%) | 2023 | 0.2% | |
|
Shares held by quarter
Peak holding11.4M (Q1'25)
Change over 8 quarters−3.9M
Share of the company1.950%
|
||||||
|
B
BlackRock, Inc.
|
1.4M | 5.00% | +1.4M (+3836.7%) | Q3 '25 | 0.0% | |
|
Shares held by quarter
Peak holding1.4M (Q2'26)
Change over 8 quarters+1.3M
Share of the company5.000%
|
||||||
28 more super investors behind a free account
See every manager holding Unicycive Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$3.78M | 805.7K | 2.85% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$2.89M | 616.2K | 2.18% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Unicycive Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
GS
Gupta Shalabh K.
Insider
|
6.0M | 21.13% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company21.130%
|
||||||
|
AG
Aggarwal Gaurav
Insider
|
5.3M | 18.61% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company18.610%
|
||||||
Loading...